Geneoscopy Receives New York State Department of Health Permit, Expanding Ability to Provide Laboratory Services Nationwide (Business Wire)

Geneoscopy, Inc. has received a New York State Department of Health laboratory permit, allowing it to offer services across all 50 states. Its first commercial test, ColoSense™, is a noninvasive RNA-based stool screening test for colorectal cancer and advanced adenomas. The approval underscores Geneoscopy’s high-quality standards, meeting the rigorous requirements of the Clinical Laboratory Evaluation Program (CLEP). The company aims to improve early detection of colorectal cancer by providing a reliable and accessible testing option to patients nationwide.